Pimozide Augmentation of Clozapine in Hebephrenic Schizophrenia: A Case Report

Poor outcome hebephrenic schizophrenia patients are clinically challenging. In this report, we demonstrate the usefulness of pimozide add-on thereapy to ongoing clozapine regime in a case who poorly reponded to clozapine, ECT and adequate trials with at least two conventional antipsychotics.

Detalles Bibliográficos
Autores principales: Mendhekar, D.N., Gupta, Deepak, Lohia, Deep, Jiloha, R.C.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2003
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951543/
https://www.ncbi.nlm.nih.gov/pubmed/21206816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951543/
https://www.ncbi.nlm.nih.gov/pubmed/21206816

Ejemplares similares